Frontiers in Cardiovascular Medicine (Apr 2022)
Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury in Patients With Congestive Heart Failure
- Bo Wang,
- Bo Wang,
- Yiying Zheng,
- Yiying Zheng,
- Huanqiang Li,
- Huanqiang Li,
- Shuling Chen,
- Ziyou Zhou,
- Zhubin Lun,
- Ming Ying,
- Ming Ying,
- Lingyu Zhang,
- Ziling Mai,
- Liwei Liu,
- Ziqing Zhou,
- Mengfei Lin,
- Yongquan Yang,
- Yongquan Yang,
- Jiyan Chen,
- Jiyan Chen,
- Jiyan Chen,
- Jiyan Chen,
- Yong Liu,
- Yong Liu,
- Yong Liu,
- Yong Liu,
- Jin Liu,
- Jin Liu,
- Jin Liu,
- Jin Liu,
- Shiqun Chen,
- Shiqun Chen,
- Shiqun Chen,
- Shiqun Chen,
- Ning Tan,
- Ning Tan,
- Ning Tan,
- Ning Tan
Affiliations
- Bo Wang
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Bo Wang
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Yiying Zheng
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Yiying Zheng
- Department of Cardiology, People's Hospital of Yangjiang, Yangjiang, China
- Huanqiang Li
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Huanqiang Li
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Shuling Chen
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Ziyou Zhou
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Zhubin Lun
- The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China
- Ming Ying
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Ming Ying
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Lingyu Zhang
- Department of Cardiology, Maoming People's Hospital, Maoming, China
- Ziling Mai
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Liwei Liu
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Ziqing Zhou
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Mengfei Lin
- Department of Cardiology, Maoming People's Hospital, Maoming, China
- Yongquan Yang
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Yongquan Yang
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jiyan Chen
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jiyan Chen
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jiyan Chen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Jiyan Chen
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Yong Liu
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Yong Liu
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Yong Liu
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Yong Liu
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Jin Liu
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jin Liu
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Jin Liu
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Jin Liu
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Shiqun Chen
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Shiqun Chen
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Shiqun Chen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Shiqun Chen
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- Ning Tan
- Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Ning Tan
- Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangzhou, China
- Ning Tan
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Ning Tan
- School of Medicine, Guangdong Provincial People's Hospital, South China University of Technology, Guangzhou, China
- DOI
- https://doi.org/10.3389/fcvm.2022.763656
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundDifferent definitions of contrast-associated acute kidney injury (CA-AKI) have different predictive effects on prognosis. However, few studies explored the relationship between these definitions and long-term prognosis in patients with congestive heart failure (CHF). Thus, we aimed to evaluate this association and compared the population attributable risks (PAR) of different CA-AKI definitions.MethodsThis study enrolled 2,207 consecutive patients with CHF undergoing coronary angiography (CAG) in Guangdong Provincial People's Hospital. Two different definitions of CA-AKI were used: CA-AKIA was defined as an increase ≥.5 mg/dl or > 25% in serum creatinine (SCr) from baseline within 72 h after CAG, and CA-AKIB was defined as an increase of ≥.3 mg/dl or > 50% in SCr from baseline within 48 h after CAG. Kaplan-Meier methods and Cox regression were applied to evaluate the association between CA-AKI with long-term mortality. Population attributable risk (PAR) of different definitions for long-term prognosis was also calculated.ResultsDuring the 3.8-year median follow-up (interquartile range 2.1-6), the overall long-term mortality was 24.9%, and the long-term mortality in patients with the definitions of CA-AKIA and CA-AKIB were 30.4% and 34.3%, respectively. We found that CA-AKIA (HR: 1.44, 95% CI 1.19-1.74) and CA-AKIB (HR: 1.48, 95% CI 1.21-1.80) were associated with long-term mortality. The PAR was higher for CA-AKIA (9.6% vs. 8%).ConclusionsOur findings suggested that CA-AKI was associated with long-term mortality in patients with CHF irrespective of its definitions. The CA-AKIA was a much better definition of CA-AKI in patients with CHF due to its higher PAR. For these patients, cardiologists should pay more attention to the presence of CA-AKI, especially CA-AKIA.
Keywords
- contrast-associated acute kidney injury (CA-AKI)
- congestive heart failure (CHF)
- long-term all-cause mortality
- population attributable risk (PAR)
- coronary angiography (CAG)